SSY Group Limited's (HKG:2005) P/E Is On The Mark
Aug 01
Hong Kong (HSI) Pharma Industry Analysis
UpdatedAug 02, 2024
DataAggregated Company Financials
Companies39
- 7D0.05%
- 3M-9.8%
- 1Y-5.9%
- YTD-11.5%
Last week, the Pharma industry hasn't moved much but China Medical System Holdings is up 3.3% in that time. As for the longer term, the industry has declined 5.9% in the last year. As for the next few years, earnings are expected to grow by 11% per annum.
Industry Valuation and Performance
Has the Hong Kong Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 03 Aug 2024 | HK$418.6b | HK$459.5b | HK$32.6b | 7.5x | 12.8x | 0.9x |
| Mon, 01 Jul 2024 | HK$438.9b | HK$461.3b | HK$33.7b | 8.2x | 13x | 1x |
| Wed, 29 May 2024 | HK$469.8b | HK$463.7b | HK$33.9b | 8.6x | 13.9x | 1x |
| Fri, 26 Apr 2024 | HK$452.4b | HK$464.0b | HK$33.8b | 7.5x | 13.4x | 1x |
| Sun, 24 Mar 2024 | HK$460.5b | HK$469.9b | HK$32.8b | 7.8x | 14x | 1x |
| Tue, 20 Feb 2024 | HK$429.0b | HK$470.8b | HK$33.6b | 7.4x | 12.8x | 0.9x |
| Thu, 18 Jan 2024 | HK$427.5b | HK$471.5b | HK$33.6b | 7.2x | 12.7x | 0.9x |
| Sat, 16 Dec 2023 | HK$489.8b | HK$473.3b | HK$33.9b | 8x | 14.4x | 1x |
| Mon, 13 Nov 2023 | HK$487.0b | HK$469.2b | HK$31.9b | 7x | 15.3x | 1x |
| Wed, 11 Oct 2023 | HK$426.5b | HK$469.4b | HK$31.6b | 6.7x | 13.5x | 0.9x |
| Fri, 08 Sep 2023 | HK$421.1b | HK$469.1b | HK$31.5b | 6.7x | 13.4x | 0.9x |
| Sun, 06 Aug 2023 | HK$471.8b | HK$446.7b | HK$27.9b | 9x | 16.9x | 1.1x |
| Tue, 04 Jul 2023 | HK$492.8b | HK$445.5b | HK$27.7b | 9.7x | 17.8x | 1.1x |
| Thu, 01 Jun 2023 | HK$506.3b | HK$448.7b | HK$27.9b | 8.6x | 18.1x | 1.1x |
| Sat, 29 Apr 2023 | HK$570.2b | HK$453.7b | HK$28.8b | 9x | 19.8x | 1.3x |
| Mon, 27 Mar 2023 | HK$543.3b | HK$444.4b | HK$33.9b | 8.7x | 16x | 1.2x |
| Wed, 22 Feb 2023 | HK$609.1b | HK$445.2b | HK$35.3b | 11.3x | 17.3x | 1.4x |
| Fri, 20 Jan 2023 | HK$628.4b | HK$447.3b | HK$35.6b | 10.5x | 17.7x | 1.4x |
| Sun, 18 Dec 2022 | HK$617.3b | HK$441.6b | HK$34.7b | 10.6x | 17.8x | 1.4x |
| Tue, 15 Nov 2022 | HK$615.1b | HK$438.2b | HK$34.1b | 9.5x | 18x | 1.4x |
| Thu, 13 Oct 2022 | HK$513.9b | HK$514.3b | HK$39.0b | 7.7x | 13.2x | 1x |
| Sat, 10 Sep 2022 | HK$549.0b | HK$519.8b | HK$40.8b | 9.7x | 13.5x | 1.1x |
| Mon, 08 Aug 2022 | HK$595.4b | HK$512.4b | HK$51.8b | 7.6x | 11.5x | 1.2x |
| Wed, 06 Jul 2022 | HK$649.0b | HK$514.6b | HK$52.2b | 9.4x | 12.4x | 1.3x |
| Fri, 03 Jun 2022 | HK$586.3b | HK$515.5b | HK$52.1b | 9x | 11.3x | 1.1x |
| Sun, 01 May 2022 | HK$580.6b | HK$516.4b | HK$51.8b | 8.5x | 11.2x | 1.1x |
| Tue, 29 Mar 2022 | HK$646.9b | HK$510.1b | HK$48.8b | 11.5x | 13.3x | 1.3x |
| Thu, 24 Feb 2022 | HK$691.3b | HK$499.3b | HK$44.1b | 9.8x | 15.7x | 1.4x |
| Sat, 22 Jan 2022 | HK$733.2b | HK$497.6b | HK$43.9b | 9.9x | 16.7x | 1.5x |
| Mon, 20 Dec 2021 | HK$684.0b | HK$496.7b | HK$43.8b | 8.7x | 15.6x | 1.4x |
| Wed, 17 Nov 2021 | HK$682.7b | HK$495.8b | HK$43.4b | 9.3x | 15.7x | 1.4x |
| Fri, 15 Oct 2021 | HK$731.2b | HK$491.0b | HK$42.6b | 9.9x | 17.2x | 1.5x |
| Sun, 12 Sep 2021 | HK$812.6b | HK$489.5b | HK$42.4b | 11.6x | 19.2x | 1.7x |
| Tue, 10 Aug 2021 | HK$931.5b | HK$489.5b | HK$42.4b | 12x | 22x | 1.9x |
Price to Earnings Ratio
22x
Current Industry PE
- Investors are pessimistic on the Hong Kong Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 12.8x which is lower than its 3-year average PE of 15.1x.
- The 3-year average PS ratio of 1.2x is higher than the industry's current PS ratio of 0.91x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 8.4% per year over the last three years,
- Revenues have also declined 2.1% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | 1.31% | |
| Healthcare | 1.97% | |
| Pharma | 0.053% | |
| Pharma | 0.053% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 867 China Medical System Holdings | HK$6.62 | 3.3% +HK$512.3m | -48.8% | PE6.2x | |
| 1477 Ocumension Therapeutics | HK$6.98 | 3.4% +HK$159.5m | -27.4% | PS18.1x | |
| 570 China Traditional Chinese Medicine Holdings | HK$3.38 | 0.9% +HK$151.1m | -5.1% | PE12.2x | |
| 2877 China Shineway Pharmaceutical Group | HK$8.14 | 2.1% +HK$128.4m | -8.0% | PE5.9x | |
| 1558 YiChang HEC ChangJiang Pharmaceutical | HK$9.30 | 1.4% +HK$114.4m | 28.6% | PE3.8x |
